Should a patient become pregnant while using the solution, discontinuation is generally recommended until pregnancy and nursing have concluded
In such cases, supplementation is often recommended
(Perl, Liski, Rajamki and Vinm 2026) Due to economic and political challenges, the project however remained stagnant
For patients requiring injections, the choice of product is paramount
Composition 5-amino-1MQ: 50 mg Appearance: lyophilized powder in a sealed research vial Research Focus (non-clinical) Investigation of NNMT inhibition and its downstream metabolic effects Studies on NAD+ metabolism and energy homeostasis in preclinical models Development of analytical methods (HPLC/LC-MS) for small-molecule quantitation Stability and solubility assessment of 5-amino-1MQ under laboratory storage conditions Documentation Lot-specific COA available Batch and lot traceability Important Notice For research use only Not for human consumption Not intended to diagnose, treat, cure, or prevent any disease Quality & Manufacturing Lot-specific COA Lyophilized for transit stability
Ashour M, Hajjar W, Al-Kattan K, Essa M, Al-Motrafi AA, Al-Saddique A, et al
